上海沪震实业有限公司
扫一扫,手机逛起来
主营:ELISA试剂盒,人ELISA试剂盒,小鼠ELISA试剂盒,大鼠ELISA试剂盒,重组蛋白,金标试剂盒,**组化试剂盒,标准品,单克隆抗体,多克隆抗体,生化试剂,生物培养基,原代细胞,细胞株,实验室耗材,动物血清等产品
021-60345367
您现在的位置:
企业信息
9
  • 注册时间:2015-11-06
  • 联系人:游艳
  • 电话:021-60345367
  • 联系时,请说明仪表网看到的
  • Email:shhzsw01@163.com
在线询价
产品详情

HCC1008细胞

  • 如果您对该产品感兴趣的话,可以
  • 产品名称:HCC1008细胞
  • 产品型号:HCC1008
  • 产品展商:HZbscience
  • 产品文档:无相关文档
  • 发布时间:2016-10-10
  • 在线询价
简单介绍
HCC1008细胞应如何避免细胞污染,细胞污染的种类可分成**、酵母菌、霉菌、病毒和霉浆菌。主要的污染原因为无菌操作技术不当、操作室环境不佳、污染之血清和污染之细胞等。严格之无菌操作技术、清洁的环境、与品质良好之细胞来源和培养基配制是减低污染之*好方法。HCC1008细胞何时须更换培养基?视细胞生长密度而定,或遵照细胞株基本数据上之更换时间,按时更换培养基即可。
产品描述

HCC1008细胞

数量: 大量

生长状态: 贴壁生长

器官来源: **

年限: TNM stage IIA, grade 3

运输方式: 冻存运输

ATCC Number: CRL-2320™

相关**: 导管癌

组织来源: duct

细胞形态: 上皮样

是否是肿瘤细胞: 1

物种来源: 人

Designations: HCC1008

Depositors: AF Gazdar, AK Virmani

HCC1008细胞Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: adherent

Organism: Homo sapiens

Morphology: epithelial


Source: Organ: mammary gland; breast

Tissue: duct

Tumor Stage: TNM stage IIA, grade 3

Disease: ductal carcinoma

Derived from metastatic site: lymph node

Cellular Products: Epithelial glycoprotein 2 (EGP2)

cytokeratin 19

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Restrictions: HCC1008细胞The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. Adi F. Gazdar and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 648-1888, Email TechnologyDevelopment@UTSouthwestern.edu, or Fax: (214) 951-0935.

Isolation: Isolation date: June 7, 1994

Applications: The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR).

The cells are positive for expressions of Her2-neu and p53 oncogenes.

HCC1008 is positive for the epithelial cell specific marker, Epithelial Glycoprotein 2 (EGP2) and cytokeratin 19.

Receptors: estrogen receptor, not expressed

progesterone receptor, not expressed

Oncogene: her2/neu +, p53 +

DNA Profile (STR): Amelogenin: X

CSF1PO: 12,13

D13S317: 12

D16S539: 14,15

D5S818: 13

D7S820: 10

HCC1008细胞THO1: 7

TPOX: 11

vWA: 17,19

Cytogenetic Analysis: multiploid; cell population has several ploidy indices; double minute (DM) chromosomes were observed

Age: 67 years *****

Gender: female

Ethnicity: Black

Comments: This cell line was initiated from an axillary lymph node on 6/7/94 and took 12.5 months to establish.

The tumor was classified as TNM stage IIA, grade 3, ductal carcinoma with 12 out of 12 lymph node metastasis.

The cells are positive for expressions of Her2-neu and p53 oncogenes.

HCC1008 is positive for the epithelial cell specific marker, Epithelial Glycoprotein 2 (EGP2) and cytokeratin 19.

The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR).

Propagation: ATCC complete growth medium: HITES medium supplemented with 10% fetal bovine serum.The base medium for this cell line is ATCC-formulated DMEM:F12 Medium Catalog No.30-2006. To make the complete growth medium,add the following components to the base medium:

0.005 mg/ml Insulin

0.01 mg/ml Transferrin

30nM Sodium selenite (final conc.)

10 nM Hydrocortisone (final conc.)

10 nM beta-estradiol (final conc.)

extra 2mM L-glutamine (for final conc. of 4.5 mM)

10% fetal bovine serum (final conc.)


Atmosphere: air, 95%; carbon dioxide (CO2), 5%

Temperature: 37.0°C

Growth Conditions: HCC1008细胞This cell line grows exceedingly slow. Cells grow in patches and cultures only become 50 to 60% confluent.

Subculturing: Protocol:

Remove and discard culture medium.

Add 3.0 to 4.0 ml Cell Dissociation Buffer (GIBCO #13150-016) to cell layer and incubate at room temperature or 37C.

Observe cells under an inverted microscope until cell layer is dispersed (usually with 5 to 10 minutes).

Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.

Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

To remove Cell Dissociation Buffer, transfer cell suspension to centrifuge tube and spin at approximately 125 xg for 5 to10 minutes.

Discard supernatant and resuspend cell pellet in fresh complete growth medium. Aspirate cells with a small bore pipette. Add appropriate aliquots of cell suspension to new culture vessels.

Place culture vessels in incubators at 37�C.


Cells reattach slowly after subculture (about 50% attached and 50% in suspension). Allow flasks to remain undisturbed for at least a week for cultures to become reestablished. It can take as along as three to four weeks before cultures can be subcultured again.

Subcultivation Ratio: HCC1008细胞A subcultivation ratio of 1:2 is recommended

Medium Renewal: Every 3 to 4 days

Preservation: Freeze medium: Complete growth medium supplemented with 7.5% (v/v) DMSO

Storage temperature: liquid nitrogen vapor phase

Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2006

recommended serum:ATCC 30-2020

Medium additive:ATCC 30-2214

normal (or near-normal) cell line established from the same patient:ATCC CRL-2319

purified DNA:ATCC CRL-2320D

purified RNA:ATCC CRL-2320R

References: 38266: Gazdar AF, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78: 766-774, 1998. PubMed: 9833771

关于我们| 易展动态| 易展荣誉| 易展服务| 易家文化| 英才集结号| 社会责任| 联系我们

备案号:粤ICP备11010883号| 公安机关备案号:44040202000312| 版权问题及信息删除: 0756-2183610  QQ: 服务QQ

Copyright?2004-2017  珠海市金信桥网络科技有限公司 版权所有

行业网站百强奖牌 搜索营销*有价值奖 中小企业电子商务**服务商
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,易展仪表展览网对此不承担任何保证责任。

沪公网安备 31011702004356号